Minute lesions of alveolar damages in lungs of patients with stable chronic obstructive pulmonary disease
Journal Title: Chronic Obstructive Pulmonary Disease: Open Access - Year 2017, Vol 2, Issue 2
Abstract
Objective: To reveal the mechanism underlying recruitment of neutrophils in chronic obstructive pulmonary disease (COPD) lungs and to investigate the role of minute lesions of alveolar damage (MLADs) in emphysema development. Methods: Seventy-four lobes from 74 patients with stable COPD, and 78 lobes from 78 patients without COPD (controls) were immunohistochemically examined. Results: MLADs presented as microscopic foci of inflammatory lung injury where alveolar epithelial cells had fragmented and disappeared, and ring-like or tubelike capillary structures had disappeared from the alveolar septae. MLADs were detected in 11 of 74 COPD patients. Tumor necrosis factor (TNF) -α+ macrophages and hypoxia inducible factor (HIF)-2α+ macrophages were detected in 100% of patients in the smoking group with or without COPD and in all patients with COPD exhibiting MLADs. The numbers of neutrophils in alveolar septae and alveolar spaces were significantly larger in the COPD smoking group and non-COPD smoking group than in the non-COPD non-smoking group, and the numbers of neutrophils were tend to be larger in and around MLADs than in lung tissues located away from MLADs in smoking patients with COPD. Masson body-like tissues estimated to be organizations of exudates as well as mild interstitial fibrosis estimated to represent the fibroproliferative phase of MLADs were observed in patients with COPD and smoking patients without COPD. Conclusion: These findings suggest the followings: (1). HIF-2αï¼macrophages and TNF-αï¼macrophages induced by hypoxia caused by smoking play an important role in the recruitment of neutrophils, (2). MLADs develop in lungs in which large number of neutrophils have been recruited probably by deterioration of hypoxia and play an important role in the development of subsequent full-scale emphysema.
Authors and Affiliations
Iwao Emura, Hiroyuki Usuda, Kazuhiro Satou
COPD Treatment in Real Life and Randomized Controlled Trials: Is There Any Difference between Both Settings?
In the last decade, for treatment of patients with chronic obstructive pulmonary disease (COPD) a myriad of new medications, mostly administered in new inhalation devices were introduced on the market. In addition, All,...
Relation between Cor Pulmonale Status and Metrics of Six Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease: A Cross Sectional Study
Background: Cor pulmonale is a complication of chronic obstructive pulmonary disease (COPD). The use of the six minute walk test (6MWT) to discriminate between COPD patients with and without cor pulmonale remains unclear...
Thrombomodulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Background: Acute exacerbation (AE) is known as a leading cause of morbidity and mortality in chronic fibrosing group includes idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP). There is n...
Individualized Care in COPD: Updated Guidelines from Revised GOLD 2017 Report
Chronic obstructive lung disease (COPD) is a major cause of morbidity and mortality around the world. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) program provides evidence based guidelines to optimi...
Minute lesions of alveolar damages in lungs of patients with stable chronic obstructive pulmonary disease
Objective: To reveal the mechanism underlying recruitment of neutrophils in chronic obstructive pulmonary disease (COPD) lungs and to investigate the role of minute lesions of alveolar damage (MLADs) in emphysema develop...